Clinical Trials Directory

Trials / Terminated

TerminatedNCT00215033

Relationship Between EBV and PTLD

Relationship Between Quantitative Epstein-Bar Viral(EBV) Titres and Post-Transplant Lymphoproliferative Disease

Status
Terminated
Phase
Study type
Observational
Enrollment
160 (actual)
Sponsor
Children's Healthcare of Atlanta · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the significance of an elevated quantitative EBV PCR and to determine the relationship between a EBV PCR value and the risk of developing PTLD.

Detailed description

The relationship between Epstein-Barr virus and lymphoproliferative disease has been established, particularly in the immuno-suppressed patient. Over the past several years a quantitative EBV PCR lab test has been established. Unfortunately, the significance of an elevated test remains unclear. The relationship of a particular EBV PCR value and the risk of developing PTLD is unknown. The primary aims will be to determine the significance of an elevated quantitative EBV PCR and to determine the relationship between a EBV PCR value and the risk of developing PTLD. The study will be conducted through a retrospective chart review of approximately 160 patients and we will look at postoperative data including Quantitative EBV PCR results, the presence / absence of PTLD and the treatment of PTLD and results of EBV PCR with treatment.

Conditions

Timeline

Start date
2005-04-01
Completion
2006-05-01
First posted
2005-09-22
Last updated
2012-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00215033. Inclusion in this directory is not an endorsement.